Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00418587 · ClinicalTrials.gov registry record · Phase 1
Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 1 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT00418587 is a Phase 1 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 18 participants.
The verdict
NCT00418587, a Phase 1 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to test the safety and effectiveness of different doses of vitamin D in patients with Systemic Lupus Erythematosus (SLE). A long term goal is to determine if vitamin D could be used as a treatment and/or preventative of SLE.
Interventions
- DRUG Cholecalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2006-12 |
| Est. Completion | 2014-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00418587
The ClinicalTrials.gov registry entry for NCT00418587 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cholecalciferol is the first listed.
NCT00418587 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00418587 about?
NCT00418587 is a clinical study titled "Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE)". The purpose of this study is to test the safety and effectiveness of different doses of vitamin D in patients with Systemic Lupus Erythematosus (SLE). A long term goal is to determine if vitamin D could be used as a treatment and/or preventative of SLE.
What is the current status of trial NCT00418587?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2006-12. Estimated completion is 2014-08.
What interventions are being tested in trial NCT00418587?
The interventions under investigation include: Cholecalciferol (DRUG).
Who is sponsoring clinical trial NCT00418587?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.